<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn fn-type="other">
  <p>
   <bold>Contributors:</bold> JMvL, TRDJR and MCV conceived the study. FCCvR-B, HG, JOF, AHS, FB-M, MCV, AEV, JKdV-B, JHC, TRDJR, JMvL and MCV designed the study protocol. FCCvR-B, HG, JOF, JMvL and MCV drafted this manuscript. FCCvR-B, HG, JOF, AHS, FB-M, MCV, AEV, JKdV-B, JHC, TRDJR, JMvL and MCV critically revised the manuscript. FCCvR-B, HG, JOF, AHS, FB-M, MCV, AEV, JKdV-B, JHC, TRDJR, JMvL and MCV read and approved the final manuscript.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Funding:</bold> The MANUS Trial is funded by a ZonMw Translational Adult Stem Cell Research Programme grant (no: 116003005).
  </p>
 </fn>
 <fn fn-type="COI-statement">
  <p>
   <bold>Competing interests:</bold> JMvL received honoraria from Arthrogen, BMS, Eli Lilly, Janssen, MSD, Pfizer, Roche, and research grants from Astra Zeneca, Genentech, MSD.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Patient consent:</bold> Not required.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Ethics approval:</bold> Ethical approval for the MANUS Trial was granted by the Dutch Central Committee for Research on Human subjects (protocol no: NL51705.000.15).
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Provenance and peer review:</bold> Not commissioned; externally peer reviewed.
  </p>
 </fn>
 <fn fn-type="other">
  <p>
   <bold>Collaborators:</bold> F C C van Rhijn-Brouwer, H Gremmels, J O Fledderus, A H Schuurman, S Zeddies, I C M Slaper-Cortenbach, M J H de Hair, A C A Marijnissen, J Tekstra, E Ton, P M J Welsing, F Bonte-Mineur, M C Vonk, A E Voskuyl, J K de Vries-Bouwstra, J H Coert, T R D J Radstake, J M van Laar, M C Verhaar.
  </p>
 </fn>
</fn-group>
